Podcast
Questions and Answers
What is Chronic Kidney Disease (CKD)?
What is Chronic Kidney Disease (CKD)?
How is CKD classified?
How is CKD classified?
What factors influence the prognosis of CKD?
What factors influence the prognosis of CKD?
Which of the following is a clinical risk factor for CKD?
Which of the following is a clinical risk factor for CKD?
Signup and view all the answers
Which sociodemographic factor is NOT a risk for CKD?
Which sociodemographic factor is NOT a risk for CKD?
Signup and view all the answers
What is a key component of ESRD pathophysiology?
What is a key component of ESRD pathophysiology?
Signup and view all the answers
What lifestyle modification is recommended for CKD patients?
What lifestyle modification is recommended for CKD patients?
Signup and view all the answers
First-line therapy for proteinuria management in diabetic CKD often includes:
First-line therapy for proteinuria management in diabetic CKD often includes:
Signup and view all the answers
Study Notes
Chronic Kidney Disease (CKD)
- CKD is characterized by abnormalities in kidney structure or function lasting 3 months or longer
- CKD is classified according to glomerular filtration rate (GFR) and albumin-to-creatinine ratio (uACR)
- End-stage renal disease (ESRD) is defined as GFR < 15 mL/min/1.73 m² or requiring dialysis/kidney transplantation
CKD Prognosis Factors
- Factors influencing CKD prognosis: cause of kidney disease, GFR at diagnosis, and albuminuria level
CKD Risk Factors
- Key clinical risk factors identified include diabetes and high blood pressure
CKD Pathophysiology and Symptoms
- Key component of ESRD pathophysiology is nephron loss
- Common symptoms in stages 4-5 of CKD include fatigue, weakness, and breathlessness
CKD Treatment Goals
- A major goal of CKD treatment is to delay or prevent disease progression
CKD Medications/Lifestyle Modifications
- First-line therapy for diabetic CKD often includes ACE inhibitors or ARBs
- Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are used to slow progression and reduce GFR decline.
- Target blood pressure for CKD patients is <140/90 mm Hg
- Common interventions for anemia of CKD include iron therapy
- Target hemoglobin level for CKD patients on dialysis is 11-12 g/dL
- Calcimimetics are used to manage secondary hyperparathyroidism in CKD
- Phosphate-binding agents are used to manage hyperphosphatemia
Other Key Information
- CKD-related cardiovascular disease (CVD) is a major contributor to morbidity and mortality in CKD patients
- Statins are used to manage CVD risk in CKD
- KDIGO guidelines recommend against initiating statin therapy in dialysis-dependent CKD patients
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz delves into Chronic Kidney Disease (CKD), covering its classification, prognosis factors, risk factors, pathophysiology, symptoms, and treatment goals. Understand the key aspects and medications that play a role in managing CKD effectively.
